Estrogen and androgen deficiency from menopause causes vulvovaginal and urogenital changes and a plethora of symptoms, most prominently dyspareunia.
Read the supplement and earn CME credit for your knowledge of the following:
- The pathophysiology of dyspareunia due to vulvovaginal atrophy (VVA) of menopause.
- The underrecognition and undertreatment of dyspareunia due to VVA.
- Efficacy results of randomized placebo controlled trials of ospemifene.
- Adverse events associated with ospemifene.
- Safety data of ospemifine as well as other oral selective estrogen receptor modulators and estrogens.
Click on the image above or here to read the supplement and earn credit